Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.36 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29035556 | 0.77 | TSHR (0.43) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL1071909 | 0.77 | TSHR (0.47) | ALDH1A1TSHRTDP1 | |
| SCHEMBL961094 | 0.75 | ALDH1A1 (0.44) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL467594 | 0.75 | ALDH1A1 (0.52) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL11576056 | 0.75 | ALDH1A1 (0.50) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL15065707 | 0.74 | — | — | |
| SCHEMBL17061002 | 0.72 | — | — | |
| SCHEMBL523853 | 0.72 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL2415583 | 0.72 | ALDH1A1 (0.46) | ALDH1A1LMNAHSD17B10TSHRCHRM5 | |
| SCHEMBL552010 | 0.72 | GSTP1 (0.37) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024009957-A1 | LIGHT/MOISTURE CURABLE RESIN COMPOSITION, CURED PRODUCT, USE OF LIGHT/MOISTURE CURABLE RESIN COMPOSITION, AND END FACE PROTECTION METHOD | 積水化学工業株式会社 | 2024-01-11 | — | — | WO | disclosed |
| WO-2023176795-A1 | LIGHT-MOISTURE CURABLE RESIN COMPOSITION, ADHESIVE AGENT FOR ELECTRONIC COMPONENT, AND ADHESIVE AGENT FOR DISPLAY ELEMENT | 積水化学工業株式会社 | 2023-09-21 | — | — | WO | disclosed |
| WO-2023153514-A1 | PHOTO/MOISTURE-CURABLE RESIN COMPOSITION, ADHESIVE FOR ELECTRONIC COMPONENT, AND ADHESIVE FOR DISPLAY ELEMENT | 積水化学工業株式会社 | 2023-08-17 | — | — | WO | disclosed |
| WO-2022260053-A1 | PHOTO/MOISTURE-CURABLE RESIN COMPOSITION, ADHESIVE FOR ELECTRONIC COMPONENTS, CURED BODY, AND ELECTRONIC COMPONENT | 積水化学工業株式会社 | 2022-12-15 | — | — | WO | disclosed |
| EP-2604655-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2020-12-09 | — | — | EP | disclosed |
| WO-2020149379-A1 | PHOTO/MOISTURE CURABLE RESIN COMPOSITION AND CURED BODY | 積水化学工業株式会社 | 2020-07-23 | — | — | WO | disclosed |
| CN-107207870-B | Curable composition and cured product thereof | 株式会社钟化 | 2020-06-23 | — | — | CN | disclosed |
| EP-3246364-B1 | CURABLE COMPOSITION AND CURED ARTICLE OBTAINED THEREFROM | KANEKA CORP (JP) | 2020-03-04 | — | — | EP | disclosed |
| US-10287399-B2 | Curable composition and cured article obtained therefrom | KANEKA CORPORATION (JP) | 2019-05-14 | — | — | US | disclosed |
| US-RE46688-E1 | Curable composition | KANEKA CORPORATION (JP) | 2018-01-30 | — | — | US | disclosed |
| US-20130217828-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| EP-2604655-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2013-06-19 | — | — | EP | disclosed |
| US-20120196981-A1 | METHOD FOR PRODUCING a-HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF | KANEKACORPORATION (JP) | 2012-08-02 | — | — | US | disclosed |
| EP-2392600-A1 | Polymer having a reactive silicon-containing group, methods for its preparation and a curable composition comprising the polymer | Kaneka Corporation (JP) | 2011-12-07 | — | — | EP | disclosed |
| EP-2386561-A1 | Methods for producing alkoxyhydrosilanes | Kaneka Corporation (JP) | 2011-11-16 | — | — | EP | disclosed |
| US-8039142-B2 | Battery case | SONY CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20110207886-A1 | Method for Producing a-hereto-Substituted Alkylhalohydrosilane and Use Thereof | KANEKA CORPORATION (JP) | 2011-08-25 | — | — | US | disclosed |
| EP-2308884-A1 | METHOD FOR PRODUCING -HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF | Kaneka Corporation (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-20090247712-A1 | CURABLE ORGANIC POLYMER AND METHOD FOR PRODUCTION THEREOF, AND CURABLE COMPOSITION CONTAINING THE SAME | KANEKA CORPORATION (JP) | 2009-10-01 | — | — | US | disclosed |
| EP-2080777-A1 | HARDENING ORGANIC POLYMER, PROCESS FOR PRODUCING THE SAME, AND HARDENING COMPOSITION CONTAINING THE POLYMER | Kaneka Corporation (JP) | 2009-07-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120196981-A1 | METHOD FOR PRODUCING a-HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF | ARSA, HACL2, AS3MT | ALDH1A1 2288/4885LMNA 1777/4885HSD17B10 422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.